Cargando…
Changes in brain activity with tominersen in early-manifest Huntington’s disease
It is unknown whether alterations in EEG brain activity caused by Huntington’s disease may be responsive to huntingtin-lowering treatment. We analysed EEG recordings of 46 patients (mean age = 47.02 years; standard deviation = 10.19 years; 18 female) with early-manifest Stage 1 Huntington’s disease...
Autores principales: | Hawellek, D J, Garces, P, Meghdadi, A H, Waninger, S, Smith, A, Manchester, M, Schobel, S A, Hipp, J F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237739/ https://www.ncbi.nlm.nih.gov/pubmed/35774187 http://dx.doi.org/10.1093/braincomms/fcac149 |
Ejemplares similares
-
Development of a population pharmacokinetic model to characterize the pharmacokinetics of intrathecally administered tominersen in cerebrospinal fluid and plasma
por: Yamamoto, Yumi, et al.
Publicado: (2023) -
Visual Object Perception in Premanifest and Early Manifest Huntington’s Disease
por: Coppen, Emma M, et al.
Publicado: (2019) -
Revealing the Timeline of Structural MRI Changes in Premanifest to Manifest Huntington Disease
por: Wijeratne, Peter A., et al.
Publicado: (2021) -
Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease
por: Novak, Marianne J. U., et al.
Publicado: (2012) -
LASSI-L detects early cognitive changes in pre-motor manifest Huntington’s disease: a replication and validation study
por: Sierra, Luis A., et al.
Publicado: (2023)